People with stage 1 or stage 2 T1D between the ages of 7 and 45 research hub

VIP-1 : Preclinical type 1 diabetes: the VIP-1 Study

The VIP-1 study looks at whether a common blood pressure medicine, verapamil, can protect insulin-making cells in people at high risk of developing type 1 diabetes. Researchers want to see if taking this daily pill for 48 weeks helps keep blood sugar levels steady and delays full diabetes.